Shareholders' equity · 2011–2025
Regeneron Pharmaceuticals shareholders' equity
$31.3B+6.5% · FY2025
Regeneron Pharmaceuticals (REGN) reported $31.3B in shareholders' equity for fiscal 2025, +6.5% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $31.3B | +6.5% | Open → |
| FY20242024-12-31 | $29.4B | +13.0% | Open → |
| FY20232023-12-31 | $26.0B | +14.6% | Open → |
| FY20222022-12-31 | $22.7B | +20.8% | Open → |
| FY20212021-12-31 | $18.8B | +70.2% | Open → |
| FY20202020-12-31 | $11.0B | −0.6% | Open → |
| FY20192019-12-31 | $11.1B | +26.6% | Open → |
| FY20182018-12-31 | $8.8B | +42.5% | Open → |
| FY20172017-12-31 | $6.1B | +38.1% | Open → |
| FY20162016-12-31 | $4.4B | +21.7% | Open → |
| FY20152015-12-31 | $3.7B | +43.3% | Open → |
| FY20142014-12-31 | $2.6B | +29.8% | Open → |
| FY20132013-12-31 | $2.0B | +56.3% | Open → |
| FY20122012-12-31 | $1.3B | +158.7% | Open → |
| FY20112011-12-31 | $486M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +34.6%
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Regeneron Pharmaceuticals shareholders' equity |url=https://companiesranked.com/en/company/regeneron-pharmaceuticals/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Regeneron Pharmaceuticals shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/regeneron-pharmaceuticals/shareholders-equityBibTeX
@misc{companiesranked-en-company-regeneron-pharmaceuticals-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Regeneron Pharmaceuticals shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/regeneron-pharmaceuticals/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0000872589-26-000025 · July 30, 2026
{{cite web |title=Regeneron Pharmaceuticals shareholders' equity — 10-Q (0000872589-26-000025) |url=https://www.sec.gov/Archives/edgar/data/872589/000087258926000025/regn-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-07-30}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.